Sometimes the major annual medical meetings are jam-packed with significant and market-moving data. And then sometimes they’re like this year’s American College of Cardiology conference, with relatively limited useful data from an investing perspective.
American College of Cardiology
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Renal denervation technologies, which are already the focus of much clinical attention for the potential to treat high blood pressure without drugs, may have a bonus side-effect in keeping the heart in check, according to researchers.
The field of transcatheter mitral valve repair may move more quickly in pet populations than it does in human medicine, according to a presentation during this week’s American College of Cardiology conference in San Francisco.
Researchers are hard at work on a technology, called MitralSeal, they they hope to bring to market to treat mitral valve regurgitation in dogs.
Updated March 19, 2013, at 11:30 a.m. to reflect that the quote in paragraph 6 came from an ACC press release, not an Edwards press release.
MASSDEVICE ON CALL — The embargo breach that got Boston Scientific’s (NYSE:BSX) PREVAIL clinical trial results pulled from the lineup at the American College of Cardiology conference this weekend was "an honest mistake," according to the company, but conference organizers don’t regret canceling the presentation.
Updated March 9, 2013, at 8:30 p.m. PST with comment, slides from Boston Scientific.
"The good thing about bad news – it sells."
In the 1st study of its kind to examine the interaction between hybrid cars and implantable cardiac devices, researchers found that the electromagnetic waves generated by the green vehicles don’t pose a threat.
"Hybrid cards do not generated clinically relevant amounts of [electromagnetic interference]," according to a team of researchers from the Mayo Clinic of Arizona. "It is safe for patients with ICD to interact with hybrid cars."